New Market Report Now Available: InDex Pharmaceuticals AB -...

Jun 23, 2013 Full story:

The company has developed two products based on its technology platform. Its products include Kappaproct, which is being developed in Phase III clinical trials for the treatment of steroid resistant ulcerative colitis; and DIMS 9054, a preclinical potential treatment for steroid resistant asthma.

Full Story
mr Endurance_


#1 Jun 23, 2013
Nigeria navy recruitment service form is out for more detail call 08146558553. Please don't miss this opportunity.
mr ade


#2 Jun 23, 2013
Nigeria custom recruitment service is presently going on for more information contact 08146558553.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Ulcerative Colitis Discussions

Title Updated Last By Comments
The murine appendiceal microbiome is altered in... Jul '14 Terry 1
New treatment could help those with Crohn's, co... (Oct '13) Jun '14 question 12
Study Finds No Tie Between Acne Drug Accutane a... (Mar '13) Jan '14 Zonnya 10
FDA Approves Uceris (Budesonide) for Patients W... (Jan '13) Oct '13 Chuck 2
Tax benefit, higher sales lift Santarus 2Q prof... (Aug '13) Aug '13 Brett Steele 1
Clinical and radiological characteristics of lu... (Aug '13) Aug '13 Carmen 1
Biomarkers Discovered for Inflammatory Bowel Di... (May '13) May '13 Vaccine Side effects 1
More from around the web